Clinical Trial Update: Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated dose reduction of antenatal betamethasone to prevent neonatal complications in very preterm birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Complications
• Very Preterm Birth Neonatal Complications

Drugs mentioned

• betamethasone (betamethasone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neonatal Complications | Phase 3 | Status: COMPLETED